Financial Performance Overview

Aether Industries Limited reported strong FY26 results with revenue from operations growing 38% to ₹11,601.41 million from ₹8,405.48 million in FY25. Net profit increased 38.5% to ₹2,194.63 million, while EBITDA surged 53% to ₹3,546.60 million with margins expanding to 30.57%. The company achieved basic EPS of ₹16.55 and maintained an effective tax rate of 24.61%.

Business Model and Strategic Shift

The company demonstrated a significant strategic shift toward high-value Contract/Exclusive Manufacturing (CEM) and CRAMS businesses, which now contribute 55% of total revenue (₹5,234.43 million from CEM and ₹1,045.62 million from CRAMS). This represents a fundamental transformation from traditional Large Scale Manufacturing, with a target of reaching 70% contribution from these segments. The company added 19 new marquee clients during FY26 and completed 50+ customer audits.

Operational Expansion and Capex

Aether Industries executed substantial capacity expansion including commissioning Site 3++ for exclusive manufacturing for Milliken & Company under a 10-year agreement. Site 4 (dedicated to Baker Hughes) grew revenue to ₹2,196 million, contributing 19% of total sales. Site 5 construction advanced with trials underway and commissioning expected Q1 FY27. The company acquired additional 15-acre land in Panoli for future expansion (Site 5+). FY26 capex reached ₹6,233.16 million with FY27 guidance of ₹3,000-3,500 million.

R&D Investment and Capabilities

R&D expenditure reached ₹862.13 million (7.3% of revenue) with a team of 356 scientists and engineers. The company maintained 55 occupied fume hoods with plans for 15 additional hoods by Q1 FY27 and a new R&D complex with 120 fume hoods by Q2 FY28. Currently, 55+ CRAMS projects are active with 70% focused on non-pharma/non-agro applications.

Market Diversification and Export Performance

The company successfully diversified its revenue mix with Pharmaceuticals declining to 34.2% (from 45.6%), while Oil & Gas increased to 21.1% and Material Science grew to 17.7%. Export contribution stood at 17.88% of revenue, benefiting from the China Plus One strategy and global supply chain shifts.

Financial Position and Capital Structure

Total assets increased to ₹32,014.26 million with property, plant and equipment at ₹11,499.44 million and capital work-in-progress of ₹4,742.04 million. Borrowings increased to ₹4,416.62 million (from ₹1,825.29 million) as the company utilized ₹2,122.81 million of short-term borrowing for long-term capex. Net debt-equity ratio stood at 0.30 with current ratio of 1.78. Net worth reached ₹24,558.88 million with return on net worth of 8.94%.

Risk Events and Contingencies

The company faced two significant fire incidents - November 2023 at Manufacturing Facility-II causing ₹299.68 million asset damage (with ₹210 million insurance received) and March 2026 at an external warehouse resulting in ₹70 million inventory loss (insurance claim lodged). Contingent liabilities include GST demands of ₹42.62 million, income tax demand of ₹1.32 million, and bank guarantees of ₹144.44 million.

Corporate Governance and AGM

The board comprises 12 directors (4 Executive, 2 Non-Executive, 6 Independent) with 4 board meetings conducted. The 14th AGM is scheduled for September 11, 2026, featuring proposals to reappoint four executive directors and ratify cost auditor remuneration for FY27. Managerial remuneration totaled ₹67.25 million for key management personnel.

ESG and Sustainability Initiatives

The company achieved Silver Medal sustainability rating from EcoVadis, operates 31 MW solar capacity, maintains zero liquid discharge systems, and spent ₹33.62 million on CSR initiatives focused on education, healthcare, and sports.

Outlook and Guidance

For FY27, the company targets EBITDA margins of 29-30% and PAT margins of 19-20%, with plans to launch 3 new LSM products and enter electronic chemicals for the semiconductor sector. Long-term growth targets include 25% revenue growth supported by new capacity and expanding client base, with working capital days targeted to reduce to 160 days from 179 days.